Next Article in Journal
Compactness Aromaticity of Atoms in Molecules
Next Article in Special Issue
MDL-28170 Has No Analgesic Effect on CCI Induced Neuropathic Pain in Mice
Previous Article in Journal
Whole Cell Imprinting in Sol-Gel Thin Films for Bacterial Recognition in Liquids: Macromolecular Fingerprinting
Previous Article in Special Issue
trans-Resveratrol as A Neuroprotectant
Int. J. Mol. Sci. 2010, 11(4), 1253-1268; doi:10.3390/ijms11041253
Article

A Novel PARP Inhibitor L-2286 in a Rat Model of Impact Acceleration Head Injury: An Immunohistochemical and Behavioral Study

1
,
1
,
2
,
1
,
1
,
1
,
3
,
1
,
4
 and
1,*
1 Department of Neurosurgery, Medical Faculty, University of Pécs, 7623 Pécs, Hungary 2 Laboratoire de Pharmacologie de la Circulation Cérébrale, UPRES EA 2510, Université René Descartes, Paris, France 3 Department of BioChemistry, University of Pécs, 7624 Pécs, Hungary 4 Department of Experimental Zoology and Neurobiology, University of Pécs, 7624, Hungary
* Author to whom correspondence should be addressed.
Received: 3 November 2009 / Revised: 11 March 2010 / Accepted: 22 March 2010 / Published: 26 March 2010
(This article belongs to the Special Issue Neuroprotective Strategies (special issue))
View Full-Text   |   Download PDF [932 KB, uploaded 19 June 2014]   |  

Abstract

We examined the neuro/axono-protective potential of a novel poly (ADP-ribose) polymerase (PARP) inhibitor L-2286 in a rat impact acceleration brain injury model. Male Wistar rats (n = 70) weighing 300-350 grams were used to determine the most effective intracerebroventricular (i.c.v.) dose of L-2286 administered 30 min after injury, and to test the neuroprotective effect at two time points (immediately, and 30 min after injury). The neuroprotective effect of L-2286 was tested using immunohistochemical (amyloid precursor protein and mid-sized mouse anti-neurofilament clone RMO-14.9 antibody) and behavioral tests (beam-balance, open-field and elevated plus maze). At both time-points, a 100 µg/rat dose of i.c.v. L-2286 significantly (p < 0.05) reduced the density of damaged axons in the corticospinal tract and medial longitudinal fascicle compared to controls. In the behavioral tests, treatment 30 min post-injury improved motor function, while the level of anxiety was reduced in both treatment protocols.
Keywords: PARP-inhibitor; impact acceleration model; traumatic brain injury PARP-inhibitor; impact acceleration model; traumatic brain injury
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).
SciFeed

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
RIS
MDPI and ACS Style

Kövesdi, E.; Bukovics, P.; Besson, V.; Nyirádi, J.; Lückl, J.; Pál, J.; Sümegi, B.; Dóczi, T.; Hernádi, I.; Büki, A. A Novel PARP Inhibitor L-2286 in a Rat Model of Impact Acceleration Head Injury: An Immunohistochemical and Behavioral Study. Int. J. Mol. Sci. 2010, 11, 1253-1268.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert